Roivant’s urology subsidiary files for $150M IPO

Urovant Sciences Ltd. (London, U.K) proposed Friday to

Read the full 88 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE